Panmure Gordon Reaffirms “Buy” Rating for Faron Pharmaceuticals Oy (LON:FARN)
Faron Pharmaceuticals Oy (LON:FARN)‘s stock had its “buy” rating restated by equities researchers at Panmure Gordon in a research note issued to investors on Monday, October 2nd.
Faron Pharmaceuticals Oy (LON:FARN) remained flat at GBX 840.00 during trading on Monday. The company’s stock had a trading volume of 284 shares. The stock’s market capitalization is GBX 229.24 million. Faron Pharmaceuticals Oy has a 12 month low of GBX 245.00 and a 12 month high of GBX 900.00. The firm has a 50-day moving average price of GBX 791.96 and a 200 day moving average price of GBX 727.97.
In related news, insider Jonathan Knowles bought 63,000 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The shares were purchased at an average cost of GBX 725 ($9.53) per share, with a total value of £456,750 ($600,512.75). Also, insider Frank Armstrong acquired 1,250 shares of the stock in a transaction on Wednesday, October 11th. The shares were acquired at an average cost of GBX 800 ($10.52) per share, for a total transaction of £10,000 ($13,147.52).
Faron Pharmaceuticals Oy Company Profile
Receive News & Stock Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related stocks with our FREE daily email newsletter.